Manhattan Research Offers Market Data, Insight, and Analysis on How Type 1 and Type 2 Diabetes Patients Use the Internet to Make Product and Treatment Decisions
March 2, 2009, New York, NY – More than ever, type 1 and type 2 diabetes patients are turning to online channels to research treatment and product information, to seek advice and support from others, and to manage their condition. According to pharmaceutical and healthcare market research company Manhattan Research’s Cybercitizen Health™ study, nine out of ten online diabetes patients use the Internet to research health information, and two-thirds use the Internet to access pharmaceutical product information.
More so than other therapeutic categories, diabetes patients have an extremely active blog community. Celebrity diabetes patients have also gotten involved in the online mix – singer Nick Jonas teamed up with Bayer Healthcare to launch NickSimpleWins.com, a diabetes awareness site featuring a blog, online videos, and links to songs from The Jonas Brothers.
A few diabetes product websites have been particularly successful in serving the needs of consumers online over the past year. According to Manhattan Research’s ePharma Consumer® study, Sanofi-Aventis’ Lantus.com is the highest-rated site in terms of visitor satisfaction, out of a pool of more than 200 product websites. Consumers applaud the site’s “very informative, interactive instruction guides” and appreciate that “all medical information is thoroughly disclosed.” Consumers also rated Merck’s Januvia.com as one of the top pharmaceutical product brand sites for visitor satisfaction.
Request a Complimentary Overview of Online Diabetes Market
Manhattan Research offers a complimentary overview of how diabetes patients use the Internet and other technology for healthcare. This one-page snapshot is a preview of the Diabetes Segmentation Module, which is a comprehensive analysis of the diabetes patient market based on Cybercitizen Health™ and ePharma Consumer®. To request your complimentary snapshot of the online diabetes market or any of the other 100+ consumer therapeutic groups we cover, please visit
www.manhattanresearch.com/products/Therapeutic_Segmentations/therapeutic-segmentation-overview-request.aspx
Consumer and Physician Segmentation Modules
Manhattan Research provides comprehensive analyses of over 125+ consumer therapeutic and physician specialist groups. Each Segmentation Module is an in-depth view of a particular market’s adoption and use of the Internet and other technology for healthcare, treatment, and product decisions and focuses heavily on tactical execution. The segmentation modules provide clients with the necessary market data and insights to make better informed decisions during brand planning and to connect with a particular disease class or specialist group through digital strategies.
Consumer therapeutic module topics include media consumption across traditional and alternative resource channels, website usage metrics, connectivity and interaction with physicians, health site engagement, use of branded and unbranded product sites, Web 2.0, interest in online health services and tools, DTC advertising, actions taken offline after health info seeking, and drivers to requesting a prescription drug.
Physician specialist module topics include interactive detailing, Web 2.0, pharmaceutical customer service portals, tech-enabled sales reps, search engines, online and offline professional information sources, email use and opportunity, patient interaction and education, digital health infrastructure, and mobile technology profile.
For a list of available consumer therapeutic segmentation modules and topics, please visit
www.manhattanresearch.com/products/Therapeutic_Segmentations
For a list of available physician specialist segmentation modules and topics, please visit
www.manhattanresearch.com/products/Specialist_Segmentations
For additional segmentation module product and purchasing information, please contact
sales@manhattanresearch.com or call 1.888.680.0800, ext 2.